首页> 美国卫生研究院文献>other >Development of Guanidinium-rich Protein Mimics for Efficient siRNA Delivery into Human T Cells
【2h】

Development of Guanidinium-rich Protein Mimics for Efficient siRNA Delivery into Human T Cells

机译:有效向人T细胞中高效siRNA输送的富胍基蛋白质模拟物的开发

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

RNA interference is gaining attention as a means to explore new molecular pathways and for its potential as a therapeutic; however, its application in immortal and primary T cells is limited due to challenges with efficient delivery in these cells types. Herein, we report the development of guanidinium-rich protein transduction domain mimics (PTDMs) based on a ring-opening metathesis polymerization scaffold that delivers siRNA into Jurkat T cells and human peripheral blood mononuclear cells (hPBMCs). Homopolymer and block copolymer PTDMs with varying numbers of guanidinium moieties were designed and tested to assess the affect cationic charge content and the addition of a segregated, hydrophobic block had on siRNA delivery. Delivery of fluorescently-labeled siRNA into Jurkat T cells illustrates that the optimal cationic charge content, 40 charges per polymer, leads to higher efficiencies, with block copolymers outperforming their homopolymer counterparts. PTDMs also outperformed commercial reagents commonly used for siRNA delivery applications. Select PTDM candidates were further screened to assess the role PTDM structure has on the delivery of biologically active siRNA into primary cells. Specifically, siRNA to hNOTCH1 was delivered to hPBMCs enabling 50–80% knockdown efficiencies, with longer PTDMs showing improved protein reduction. By evaluating the PTDM design parameters for siRNA delivery, more efficient PTDMs were discovered that improved delivery and gene knockdown in T cells. Given the robust delivery of siRNA by these novel PTDMs, their development should aid in the exploration of T cell molecular pathways leading eventually to new therapeutics.
机译:RNA干扰作为一种探索新的分子途径及其作为治疗手段的潜力而受到关注。然而,由于在这些细胞类型中有效递送的挑战,其在永生和原代T细胞中的应用受到限制。在本文中,我们报告了基于开环复分解聚合支架的富胍基蛋白转导域模拟物(PTDMs)的开发,该支架将siRNA输送到Jurkat T细胞和人外周血单核细胞(hPBMC)中。设计并测试了具有不同数量胍基部分的均聚物和嵌段共聚物PTDM,以评估阳离子电荷含量的影响以及添加分离的疏水性嵌段对siRNA的传递。将荧光标记的siRNA输送至Jurkat T细胞表明,最佳的阳离子电荷含量(每个聚合物40个电荷)导致更高的效率,其中嵌段共聚物的性能优于同聚物。 PTDM的性能也优于通常用于siRNA递送应用的商业试剂。进一步筛选了选定的PTDM候选物,以评估PTDM结构对将生物活性siRNA传递到原代细胞中的作用。具体而言,将hNOTCH1的siRNA传递至hPBMC,可实现50-80%的敲低效率,而更长的PTDM显示出更好的蛋白质还原效果。通过评估siRNA传递的PTDM设计参数,发现了更有效的PTDM,可改善T细胞中的传递和基因敲低。鉴于这些新型PTDM能够强大地传递siRNA,它们的发展将有助于探索T细胞分子途径,最终导致新的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号